PAP. Shaik Syed Ali

P. Shaik Syed Ali

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


P. Shaik Syed Ali has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • microRNA-155: a versatile noncoding RNA

    by P. Shaik Syed Ali, Parwez Ahmad, K. M. Huria Parveen

    MicroRNAs (miRNAs) are ~ 22-nucleotide-long noncoding RNAs that regulate gene expression at the post-transcriptional level through mRNA cleavage or translational repression. To date, approximately 2,700 mature human miRNAs have been identified, although biological functions have been assigned to fewer than 600. Among these, miR-155 has emerged as a regulatory miRNA with important roles in metabolism, immune homeostasis, and disease pathogenesis. Dysregulated miR-155 expression has been implicated in metabolic disorders, including diabetes and preeclampsia, as well as autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus. Mechanistic and preclinical evidence indicates that aberrant miRNA-155 expression contributes to tumorigenesis by modulating tumor suppressor genes in hematologic malignancies and solid tumors. This review summarizes the current updates on the physiological and pathological roles of miRNA-155.


  • Lin28/let-7 axis in breast cancer

    by P. Shaik Syed Ali, Parwez Ahmad, K. M. Huria Parveen

    Let-7 microRNAs are tumor suppressor microRNAs, and their reduced expression frequently occurs in various types of cancers, including breast cancer. A notable correlation exists between decreased let-7 microRNA levels and the overexpression of Lin28A and Lin28B, particularly in breast cancer cases with poor prognoses. Dysregulation of Wnt signaling significantly contributes to the upregulation of Lin28A and Lin28B in breast cancer. Both Lin28A and Lin28B operate from different cellular compartments to inhibit the biogenesis of let-7 microRNAs, which are essential for the post-transcriptional regulation of genes involved in key cellular functions such as proliferation, differentiation, and apoptosis. Decreased expression of let-7 microRNAs leads to the overexpression of oncogenes such as K-ras, C-myc, and SOX-2 in breast cancer. Overexpression of Lin28A associated with reduced let-7 microRNA levels is observed in estrogen receptor positive, estrogen receptor negative, and human epidermal growth factor receptor 2 positive breast cancers, whereas Lin28B overexpression with reduced let-7 microRNA levels occurs specifically in triple negative breast cancer. This review aims to dissect the molecular interplay between Lin28A, Lin28B, and let-7 microRNAs, elucidating their roles in breast carcinogenesis, metastasis, and the development of resistance to conventional treatments like radiation and chemotherapy. Additionally, the review addresses potential therapeutic avenues offered by let-7 microRNAs or their mimics, as well as Lin28A and Lin28B inhibitors, in the treatment of breast cancer.


  • MicroRNAs in diabetes mellitus

    by P. Shaik Syed Ali, Parwez Ahmad, K. M. Huria Parveen

    Diabetes mellitus is one of the most common chronic diseases, with a global distribution. Its prevalence is constantly increasing, along with the rising incidence of diabetes-related complications such as diabetic nephropathy, neuropathy, and retinopathy. MicroRNAs are endogenous, non-coding RNAs that regulate gene expression at the post-transcriptional level. Evidence suggests that altered microRNA expression has been implicated in various human disorders, including diabetes mellitus. Dysregulated expression of microRNAs leads to insulin resistance, causing diabetes mellitus and its associated complications. Moreover, other non-coding RNAs, such as long non-coding RNAs and circular RNAs, along with epigenetic factors and altered gut microbiota, contribute to disease development. Because of the stability of non-coding RNAs in circulation, they have the potential to be used as biomarkers for diagnosis and therapeutic implications. Evidence suggests that a myriad of factors are involved; hence, a collective approach involving non-coding RNAs, epigenetic factors, and gut microbiota could provide the best clinical outcomes for diabetes patients. The online version contains supplementary material available at 10.1007/s40200-025-01591-y.


  • Open Access

    TREATMENT OUTCOMES IN PCOS (POLYCYSTIC OVARIAN SYNDROME)-RELATED INFERTILITY

    by Aminath Efa Ibrahim, Fathimath Ina Shareef, Ahmed Yazdhan, Ahmed Shabin, P. Shaik Syed Ali, Parwez Ahmad

    Polycystic ovarian syndrome (PCOS) is one of the underdiagnosed endocrine disorders found to be prevalent among females in the reproductive age group. PCOS effects on an average 8-13% of reproductive aged women, globally. This condition is responsible for causing distress physiologically and psychologically paving the way for a poor quality of life. One of the devastating complications of PCOS is infertility. At present, there is no treatment for PCOS but could be managed by alternate options such as lifestyle modification to in-vitro fertilization. The primary objective of this review article is to analyze the outcomes of certain pharmacological treatment options such as clomiphene citrate which is a selective estrogen receptor modulator, Letrozole an aromatase inhibitor, and gonadotropins for PCOS-related infertility. Clomiphene citrate binds to estrogen receptors indirectly increasing the gonadotropins. Studies confirm a 35-40% successful outcome. Letrozole similarly increases gonadotropins by indirectly decreasing estrogen. A notable increase in the successful outcome was observed with both clomiphene citrate and letrozole, with almost near similar results. The pregnancy outcome was approximately 40% with clomiphene citrate, while letrozole showed 50%. Notably, more side effects were observed in the administration of clomiphene citrate compared to letrozole. Human menopausal gonadotropin (hMG) and recombinant follicle-stimulating hormone (FSHr), that are gonadotropins, were used as they are directly responsible for the maturation of follicles and ovulation itself. The use of gonadotropins increased the pregnancy rate outcome to 20 -30 %, albeit with the risk of multiple births. Furthermore, we have discussed why letrozole and clomiphene citrate are used as the primary therapy compared to gonadotropins. Peer Review History: Received 22 May 2024; Reviewed 14 July 2024; Accepted 23 August; Available online 15 September 2024 Academic Editor: Dr. Rola Jadallah, Arab American University, Palestine, rola@aauj.edu Average Peer review marks at initial stage: 5.5/10 Average Peer review marks at publication stage: 7.0/10 Reviewers: Dr. George Zhu, Tehran University of Medical Sciences, Tehran, Iran, sansan4240732@163.com Dr. Ogbonna B. Onyebuchi, Nnamdi Azikiwe University, Awka, Nigeria, summitpharm@yahoo.com

  • Open Access

    Epidemiology of emerging viruses

    by P Shaik Syed Ali

    Newly emerging viruses such as West Nile virus, coronaviruses (SARS-CoV, MERS-CoV and SARS-CoV-2), H1N1pdm09, Ebola virus, Zika virus and Monkeypox virus are of global concern as they have caused serious public threats. Among the several outbreaks caused by emerging viruses, the worst pandemic was caused by SARS-CoV-2. The Omicron variant is the dominant variant among SARS-CoV-2 variants and the lineages BA.5.2 and BF.7 were responsible for the recent Chinese surge. Genome sequencing studies of MERS-CoV revealed that it is evolving with mutations in spike protein. West Nile virus is still circulating among birds in Europe, Mediterranean and North American countries. Several West Nile virus cases were reported from Europe and neighboring countries in 2022. The 2009 H1N1 pandemic caused by H1N1pdm09 is a variant strain evolved from H1N1 in swine. Though it caused more than 60 million infections, the mortality rate was 0.02%. Staggeringly, severe infections occurred among obese people. Zika virus has jumped borders from Africa and is adapting to become endemic in new geographical habitats such as South East Asia, India and Europe due to uncontrolled breeding of Aedes mosquitoes. Recently, autochthonous vector borne transmission of Zika virus was documented in France. During the Monkeypox pandemic, the virus demonstrated a lower infectious and mortality rate in individuals vaccinated for smallpox. A lower virulence of Monkeypox virus compared to smallpox was due to mutations in the ORF regions. Surveillance efforts and measures must be incessantly undertaken to prevent future outbreaks caused by emerging viruses.


  • Open Access

    Role of miRNAs in Immune Regulation And Bacterial Infections

    by P. Shaik Syed Ali

    Micro RNAs (miRNAs) are small noncoding RNAs that regulate gene expression at the post-transcriptional level. The miRNA in the RNA-induced silencing complex acts as a guide strand and binds the target mRNA. Subsequently, the gene is silenced either by cleaving the target mRNA or repressing the translation. Since the discovery of the first miRNA three decades ago, more than 2000 human miRNAs have been discovered. It is known to regulate hundreds of genes in various physiological and pathophysiological processes, including the development and function of immunologically essential cells. miR-155 plays a vital role in the function of T helper 1, 17, and T regulatory cells. miR-24 positively regulates the function of T helper 1, 17, and T regulatory cells, whereas miR-23 and 27 have a negative regulatory effect. miR-223 regulates the differentiation of neutrophils and monocytes. The role of miRNAs in bacterial infections came to light in 2006 after discovering miR-163 as a negative regulator of defense response in Arabidopsis thaliana infected with Pseudomonas syringae. During bacterial infection in the host, aberrant expression of several miRNAs was discovered. miR-155 was found to be the most commonly dysregulated miRNA in bacterial infections such as Helicobacter pylori, Staphylococcus aureus, Listeria monocytogenes, Mycobacterium tuberculosis, and Chlamydia trachomatis. Therefore, miRNAs can be utilized as a diagnostic and prognostic tool for bacterial infections. J Microbiol Infect Dis 2022; 12(4):1-7.


  • Open Access

    Biology of tomato flu

    by P. Shaik Syed Ali, Sheeza Ali


  • Nodamura virus B2 amino terminal domain sensitivity to small interfering RNA

    by P. Shaik Syed Ali, Jasmine John, Manikandan Selvaraj, Teh Lay Kek, Mohd Zaki Salleh

    Nodamura virus (NoV) B2, a suppressor of RNA interference, binds double stranded RNAs (dsRNAs) and small interfering RNAs (siRNAs) corresponding to Dicer substrates and products. Here, we report that the amino terminal domain of NoV B2 (NoV B2 79) specifically binds siRNAs but not dsRNAs. NoV B2 79 oligomerizes on binding to 27 nucleotide siRNA. Mutation of the residues phenylalanine49 and alanine60 to cysteine and methionine, respectively enhances the RNA binding affinity of NoV B2 79. Circular dichroism spectra demonstrated that the wild type and mutant NoV B2 79 have similar secondary structure conformations.


  • Recognition of the let‐7g miRNA precursor by human Lin28B

    by P. Shaik Syed Ali, Umesh Ghoshdastider, Jan Hoffmann, Bernd Brutschy, Slawomir Filipek

    Mammalian homologs of lin28: Lin28 and Lin28B block the post‐transcriptional processing of the let‐7 family of miRNAs. We report that in vitro the terminal stem‐loop region of the let‐7g miRNA precursor (pre‐let‐7g) required to bind Lin28B is restricted to 24 nucleotides (nt) including the 3′ GGAG motif. Additionally, full length Lin28B is required for efficient binding to pre‐let‐7g and the stoichiometry of the complex is 1:1. Molecular dynamics (MD) simulations reveal the interactions of the pre‐let‐7g stem‐loop and the GGAG motif in the stem region to the cold shock domain (CSD) and to the zinc knuckle domain (ZKD) of Lin28B, respectively.